speb/financial-data huggingface dataset:
Financial ratios for MFC.TO — quarterly report dated 2025-09-30
Total revenue: 12452517985.611511
Net income: 1380575539.5683453
Capital expenditures: 0
Operating cash flow: 6860431654.676259
Depreciation & amortization: -348201438.8489209
Net tangible assets: 29110791366.906475
Owner earnings: 1032374100.7194245
Return on net tangible assets (%): 3.54636219849743
Buffett classification: The Gruesome
Stock price: 30.33093525179856
P/E ratio: 15.690434296681728
Shares outstanding: 1665674480
Book value: 38123021582.733765
P/B ratio: 1.3252219447981748
Market cap (USD): 50521464803.45324
Debt to equity: 0.25340152101300256
Effective tax rate (%): 13.907581875280394
COGS to revenue (%): 0
SG&A to revenue (%): 7.117684441619966
Free cash flow (dilution-adjusted): 6860431654.676259
Buyback yield (%): 0.8729105459635459
Retained earnings: 3661151079.136691
Capitalized R&D asset: 0
FCF margin (%): 55.09272632734415
Revenue growth (%): -58.516839780455264
Rule of 40 score: -3.4241134531111115
Financial ratios for MFC.TO — annual report dated 2025-12-31
Total revenue: 6248905109.489051
Net income: 4423357664.233577
Capital expenditures: 0
Operating cash flow: 23434306569.343063
Depreciation & amortization: -1335036496.350365
Net tangible assets: 28199270072.9927
Owner earnings: 3088321167.883212
Return on net tangible assets (%): 10.951776978231049
Buffett classification: The Gruesome
Stock price: 35.68613138686131
P/E ratio: 13.438089987986798
Shares outstanding: 1665674480
Book value: 38312408759.124146
P/B ratio: 1.5514941572778516
Market cap (USD): 59441478341.0219
Debt to equity: 0.2795877152873033
Effective tax rate (%): 14.57569777276572
COGS to revenue (%): 0
SG&A to revenue (%): 57.247985048475634
Free cash flow (dilution-adjusted): 23434306569.343063
Buyback yield (%): 2.9852093256569225
Retained earnings: 3667153284.6715326
Capitalized R&D asset: 0
FCF margin (%): 375.0146010980025
Rule of 40 score: 375.0146010980025
Financial ratios for MFC.TO — quarterly report dated 2025-12-31
Total revenue: 1014177001.5839416
Net income: 1164233576.6423357
Capital expenditures: 0
Operating cash flow: 6281751824.817518
Depreciation & amortization: -369343065.6934306
Net tangible assets: 28199270072.9927
Owner earnings: 794890510.948905
Return on net tangible assets (%): 2.818833639634509
Buffett classification: The Gruesome
Stock price: 35.68613138686131
P/E ratio: 13.558350703811255
Shares outstanding: 1665674480
Book value: 38312408759.124146
P/B ratio: 1.5514941572778516
Market cap (USD): 59441478341.0219
Debt to equity: 0.2795877152873033
Effective tax rate (%): 16.27296587926509
COGS to revenue (%): 0
SG&A to revenue (%): 95.50730663122428
Free cash flow (dilution-adjusted): 6281751824.817518
Buyback yield (%): 0.8080081185858722
Retained earnings: 3667153284.6715326
Capitalized R&D asset: 0
FCF margin (%): 619.3940323046844
Revenue growth (%): -91.85564716504894
Rule of 40 score: 527.5383851396355
Financial ratios for MLFMV.LS — annual report dated 2021-12-31
Total revenue: 908093232.9545455
Gross profit: 199906851.13636363
Operating income: 16880662.5
Net income: 10744456.818181818
Capital expenditures: 1026511.3636363636
Depreciation & amortization: 16501572.727272727
Net tangible assets: -107894657.95454545
Owner earnings: 26219518.181818184
Return on net tangible assets (%): -24.301034619215446
Capex to operating income (%): 6.080989793121945
Buffett classification: The Great
Stock price: 1.7045454545454546
P/E ratio: 0.42704916975159074
Shares outstanding: 2691868
Book value: 190887328.40909094
P/B ratio: 0.024037275820650243
Market cap (USD): 4588411.363636363
Debt to equity: 1.598318097558847
Current ratio: 0.8317454528546894
Quick ratio: 0.573786500196658
Effective tax rate (%): 51.83582742097855
Interest coverage ratio: 1.7532258862121461
COGS to revenue (%): 77.98608734414279
SG&A to revenue (%): 9.245874702405438
Free cash flow (dilution-adjusted): 14771505.681818182
Buyback yield (%): 219.4263116418289
Retained earnings: 4901192.045454546
Inventory turnover: 9.191552639986577
Receivables turnover: 8.497782619509865
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.36527954644532
FCF margin (%): 1.6266507827349448
Rule of 40 score: 1.6266507827349448
Financial ratios for MLFMV.LS — annual report dated 2022-12-31
Total revenue: 884316014.893617
Gross profit: 192245987.23404256
Operating income: 16228861.70212766
Net income: 11164542.55319149
Capital expenditures: 3180848.936170213
Depreciation & amortization: 18266626.59574468
Net tangible assets: -82665503.19148937
Owner earnings: 26250320.21276596
Return on net tangible assets (%): -31.754866539623865
Capex to operating income (%): 19.599950967313948
Buffett classification: The Great
Stock price: 2.3829787234042556
P/E ratio: 0.5745568293238378
Shares outstanding: 2691868
Book value: 194601073.4042554
P/B ratio: 0.03296314895903599
Market cap (USD): 6414664.170212767
Debt to equity: 1.4685448505294316
Current ratio: 0.8709691297102826
Quick ratio: 0.5977021164067121
Effective tax rate (%): 31.04057035247237
Interest coverage ratio: 1.9477268032247081
COGS to revenue (%): 78.260487880323
Free cash flow (dilution-adjusted): 11742064.893617023
Buyback yield (%): 0
Retained earnings: 8366576.595744682
Inventory turnover: 8.73193288007168
Receivables turnover: 8.748481568539706
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.300411811029579
FCF margin (%): 1.327813213360112
Revenue growth (%): -2.6183674977477374
Rule of 40 score: -1.2905542843876254
Financial ratios for MLFMV.LS — annual report dated 2023-12-31
Total revenue: 919566516.6666666
Gross profit: 188111727.77777776
Operating income: 17110334.444444444
Net income: 20179607.777777776
Capital expenditures: 2246646.6666666665
Depreciation & amortization: 15921235.555555556
Net tangible assets: -58513620
Owner earnings: 33854196.666666664
Return on net tangible assets (%): -57.85695136733408
Capex to operating income (%): 13.130349228188992
Buffett classification: The Great
Stock price: 1.4444444444444444
P/E ratio: 0.19268232666343532
Shares outstanding: 2691868
Book value: 226542613.33333337
P/B ratio: 0.017163454241858795
Market cap (USD): 3888253.7777777775
Debt to equity: 1.220552849433988
Current ratio: 0.8794576590004839
Quick ratio: 0.606770456836521
Effective tax rate (%): 14.902982780354412
Interest coverage ratio: 1.1387299257388677
COGS to revenue (%): 79.54343439345058
Free cash flow (dilution-adjusted): 39479928.88888889
Buyback yield (%): 0
Retained earnings: 19993902.22222222
Inventory turnover: 9.232270630754732
Receivables turnover: 8.744624064470568
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.235544921825991
FCF margin (%): 4.293319534077811
Revenue growth (%): 3.9861883285343667
Rule of 40 score: 8.279507862612178
Financial ratios for MLFMV.LS — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -24828710.416666668
Buffett classification: The Gruesome
Stock price: 1.25
Shares outstanding: 2691868
Book value: 215650659.37500006
P/B ratio: 0.015603175106220325
Market cap (USD): 3364835
Debt to equity: 1.2002016156212674
Current ratio: 1.1484584122380919
Quick ratio: 0.8694508108328669
Buyback yield (%): 0
Retained earnings: 19629451.041666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLFMV.LS — annual report dated 2024-12-31
Total revenue: 879867277.0833334
Gross profit: 178589641.6666667
Operating income: 15437869.791666668
Net income: 19145597.916666668
Capital expenditures: 14867057.291666668
Depreciation & amortization: 14425177.083333334
Net tangible assets: -24828710.416666668
Owner earnings: 18703717.708333332
Return on net tangible assets (%): -75.33100750886426
Capex to operating income (%): 96.30251771971724
Buffett classification: The Gruesome
Stock price: 1.25
P/E ratio: 0.1757497997527064
Shares outstanding: 2691868
Book value: 215650659.37500006
P/B ratio: 0.015603175106220325
Market cap (USD): 3364835
Debt to equity: 1.2002016156212674
Current ratio: 1.1484584122380919
Quick ratio: 0.8694508108328669
Effective tax rate (%): 19.426576550859153
Interest coverage ratio: 1.0255525308708484
COGS to revenue (%): 79.70266126288134
Free cash flow (dilution-adjusted): 10859800
Buyback yield (%): 0
Retained earnings: 19629451.041666668
Inventory turnover: 9.822071978390076
Receivables turnover: 11.120302592635179
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.613724004929031
FCF margin (%): 1.2342543339035272
Revenue growth (%): -4.31716889032007
Rule of 40 score: -3.0829145564165428
Financial ratios for MLFMV.LS — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 24961721.17647059
Buffett classification: The Gruesome
Stock price: 2.9411764705882355
Shares outstanding: 2691868
Book value: 327613297.64705884
P/B ratio: 0.024166475782246042
Market cap (USD): 7917258.823529412
Debt to equity: 0.7731161835372314
Current ratio: 0.9896500882904797
Quick ratio: 0.6479487344816656
Buyback yield (%): 0
Retained earnings: 68935931.76470588
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NBM.V — annual report dated 2022-02-28
Total revenue: 0
Gross profit: -58146.09375
Operating income: -1630010.9375
Net income: -1613030.46875
Capital expenditures: 138642.96875
Operating cash flow: -1156573.4375
Depreciation & amortization: 58146.09375
Net tangible assets: 1168885.15625
Owner earnings: -1693527.34375
Return on net tangible assets (%): -144.88398066266402
Buffett classification: The Gruesome
Stock price: 0.25
Shares outstanding: 154392934
Book value: 1207330.46875
P/B ratio: 31.969899293573178
Market cap (USD): 38598233.5
Debt to equity: 0.13290879995444496
Current ratio: 7.676804967963252
Quick ratio: 7.676804967963252
Interest coverage ratio: -25.671358614070922
Free cash flow (dilution-adjusted): -1842378.125
Buyback yield (%): 0
Retained earnings: -22144946.875
Receivables turnover: 0
Capitalized R&D asset: 103682.03125
ROCI (R&D-adjusted, %): -107.29094226499672
Rule of 40 score: 0
Financial ratios for NBM.V — annual report dated 2023-02-28
Total revenue: 0
Gross profit: -97242.64705882352
Operating income: -1433926.4705882352
Net income: -1231679.4117647058
Capital expenditures: 352844.85294117645
Operating cash flow: -1309245.588235294
Depreciation & amortization: 97242.64705882352
Net tangible assets: 1342377.2058823528
Owner earnings: -1487281.6176470586
Return on net tangible assets (%): -110.79461206058392
Buffett classification: The Gruesome
Stock price: 0.23529411764705882
Shares outstanding: 154392934
Book value: 2160774.9999999995
P/B ratio: 16.81237018036149
Market cap (USD): 36327749.176470585
Debt to equity: 0.06052532894311478
Current ratio: 9.244577435800007
Quick ratio: 9.244577435800007
Interest coverage ratio: -63.0052985267511
Free cash flow (dilution-adjusted): -1669015.4411764704
Buyback yield (%): 0
Retained earnings: -20886114.70588235
Receivables turnover: 0
Capitalized R&D asset: 293383.8727022059
ROCI (R&D-adjusted, %): -51.18364629374435
Rosenberg metric: -0.3770812824312171
Rule of 40 score: 0
Financial ratios for NBM.V — annual report dated 2024-02-29
Total revenue: 0
Gross profit: -152180.14705882352
Operating income: -2448569.8529411764
Net income: -2088808.088235294
Capital expenditures: 260311.0294117647
Operating cash flow: -1856284.5588235292
Depreciation & amortization: 152180.14705882352
Net tangible assets: 1471491.9117647058
Owner earnings: -2196938.970588235
Return on net tangible assets (%): -149.300105085425
Buffett classification: The Gruesome
Stock price: 0.16176470588235292
Shares outstanding: 154392934
Book value: 1638515.4411764704
P/B ratio: 15.242656206456616
Market cap (USD): 24975327.558823526
Debt to equity: 0.0968173754847129
Current ratio: 2.006404516115167
Quick ratio: 2.006404516115167
Interest coverage ratio: -111.03514387649628
Free cash flow (dilution-adjusted): -2523115.4411764704
Buyback yield (%): 0
Retained earnings: -24227486.76470588
Receivables turnover: 0
Capitalized R&D asset: 295032.7835477941
ROCI (R&D-adjusted, %): -120.7894296267299
Rosenberg metric: -0.24534770315932578
Rule of 40 score: 0
Financial ratios for NBM.V — quarterly report dated 2024-11-30
Total revenue: 0
Gross profit: -49805.71428571429
Operating income: -1361970
Net income: -1319703.5714285716
Capital expenditures: 50
Operating cash flow: -236394.28571428574
Depreciation & amortization: 49805.71428571429
Net tangible assets: 1267965
Owner earnings: -1269947.8571428573
Return on net tangible assets (%): -100.1563810627941
Buffett classification: The Gruesome
Stock price: 0.6285714285714287
Shares outstanding: 154392934
Book value: 1301975
P/B ratio: 74.53828766736251
Market cap (USD): 97046987.0857143
Debt to equity: 0.09746676066305861
Current ratio: 1.662248083803678
Quick ratio: 1.662248083803678
Interest coverage ratio: -270.07903682719547
Free cash flow (dilution-adjusted): -1298490.7142857146
Buyback yield (%): 0
Retained earnings: -25934567.142857146
Receivables turnover: 0
Capitalized R&D asset: 15238.57142857143
ROCI (R&D-adjusted, %): -95.3055806649528
Rule of 40 score: 0
Financial ratios for NBM.V — quarterly report dated 2025-02-28
Total revenue: 0
Gross profit: -50909.722222222226
Operating income: -505721.5277777778
Net income: -360155.55555555556
Capital expenditures: 6009.027777777778
Operating cash flow: -412152.0833333334
Depreciation & amortization: 50909.722222222226
Net tangible assets: 639632.6388888889
Owner earnings: -315254.86111111107
Return on net tangible assets (%): -49.286862793421996
Buffett classification: The Gruesome
Stock price: 0.47222222222222227
Shares outstanding: 154392934
Book value: 531672.2222222222
P/B ratio: 137.12917722907807
Market cap (USD): 72907774.3888889
Debt to equity: 0.21952226204532868
Current ratio: 1.161621103267077
Quick ratio: 1.161621103267077
Interest coverage ratio: -500.16414835164835
Free cash flow (dilution-adjusted): -14760.416666666686
Buyback yield (%): 0
Retained earnings: -25574318.055555556
Receivables turnover: 0
Capitalized R&D asset: 185146.6484126984
ROCI (R&D-adjusted, %): -48.37963749499588
Rosenberg metric: -0.07244825682530753
Rule of 40 score: 0
Financial ratios for NBM.V — annual report dated 2025-02-28
Total revenue: 0
Gross profit: 0
Operating income: -2951831.25
Net income: -2692802.777777778
Capital expenditures: 12915.972222222223
Operating cash flow: -1200714.5833333335
Depreciation & amortization: 195294.44444444444
Net tangible assets: 639632.6388888889
Owner earnings: -2510424.3055555555
Return on net tangible assets (%): -392.4790814171763
Buffett classification: The Gruesome
Stock price: 0.47222222222222227
Shares outstanding: 154392934
Book value: 531672.2222222222
P/B ratio: 137.12917722907807
Market cap (USD): 72907774.3888889
Debt to equity: 0.21952226204532868
Current ratio: 1.161621103267077
Quick ratio: 1.161621103267077
Interest coverage ratio: -178.2013583197082
Free cash flow (dilution-adjusted): -2285331.9444444445
Buyback yield (%): 0
Retained earnings: -25574318.055555556
Receivables turnover: 0
Capitalized R&D asset: 369292.89705882355
ROCI (R&D-adjusted, %): -291.9156914026635
Rosenberg metric: 1.3735490678860358
Rule of 40 score: 0
Financial ratios for NBM.V — quarterly report dated 2025-05-31
Total revenue: 0
Gross profit: -54484.782608695656
Operating income: -1070013.043478261
Net income: -1014912.3188405798
Capital expenditures: 100781.15942028986
Operating cash flow: -110826.81159420291
Depreciation & amortization: 54484.782608695656
Net tangible assets: 310126.81159420294
Owner earnings: -1061208.695652174
Return on net tangible assets (%): -342.18540802616974
Buffett classification: The Gruesome
Stock price: 0.41304347826086957
Shares outstanding: 154392934
Book value: 138174.63768115942
P/B ratio: 461.52460066813154
Market cap (USD): 63770994.47826087
Debt to equity: 0.8185241319271453
Current ratio: 0.291322199899548
Quick ratio: 0.291322199899548
Interest coverage ratio: -260.013734812467
Free cash flow (dilution-adjusted): -861993.4782608696
Buyback yield (%): 0
Retained earnings: -27701157.246376812
Receivables turnover: 0
Capitalized R&D asset: 220868.27235162182
ROCI (R&D-adjusted, %): -232.47977352247693
Rosenberg metric: -0.020436296267786137
Rule of 40 score: 0
Financial ratios for NBM.V — quarterly report dated 2025-08-31
Total revenue: 0
Gross profit: -61114.598540145984
Operating income: -738776.6423357663
Net income: -681087.5912408759
Capital expenditures: 44772.99270072993
Operating cash flow: -501847.4452554744
Depreciation & amortization: 61114.598540145984
Net tangible assets: 454472.2627737226
Owner earnings: -664745.9854014597
Return on net tangible assets (%): -146.26766908598566
Buffett classification: The Gruesome
Stock price: 0.3430656934306569
Shares outstanding: 154392934
Book value: 227270.07299270073
P/B ratio: 233.05716527492288
Market cap (USD): 52966918.963503644
Debt to equity: 0.8195754110996917
Current ratio: 0.45027116251460164
Quick ratio: 0.45027116251460164
Interest coverage ratio: -121.92796048668833
Free cash flow (dilution-adjusted): -742515.3284671532
Buyback yield (%): 0
Retained earnings: -28584443.065693427
Receivables turnover: 0
Capitalized R&D asset: 247189.88041494766
ROCI (R&D-adjusted, %): -122.78095419840606
Rosenberg metric: -0.06721777642971562
Rule of 40 score: 0
Financial ratios for NBM.V — quarterly report dated 2025-11-30
Total revenue: 0
Gross profit: -60910.00000000001
Operating income: -1762880
Net income: -1704125
Capital expenditures: 5241.428571428572
Operating cash flow: -3595128.571428572
Depreciation & amortization: 60910.00000000001
Net tangible assets: 6380397.857142857
Owner earnings: -1648456.4285714286
Return on net tangible assets (%): -25.836263905172952
Buffett classification: The Gruesome
Stock price: 0.35000000000000003
Shares outstanding: 154392934
Book value: 5979672.142857144
P/B ratio: 9.036871187753842
Market cap (USD): 54037526.900000006
Debt to equity: 0.027435092296627345
Current ratio: 8.598075412802084
Quick ratio: 8.598075412802084
Interest coverage ratio: -11.98486857120658
Free cash flow (dilution-adjusted): -4158992.8571428573
Buyback yield (%): 0
Retained earnings: -29676044.285714287
Receivables turnover: 0
Capitalized R&D asset: 205864.21829804598
ROCI (R&D-adjusted, %): -28.201748295503435
Rosenberg metric: 0.0016583149437663092
Rule of 40 score: 0
Financial ratios for NTD.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7368421052631579
Shares outstanding: 167707610
Market cap (USD): 123574028.42105262
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTD.AX — annual report dated 2022-06-30
Total revenue: 384764827.5862069
Gross profit: 110418620.68965517
Operating income: 13000000
Net income: 6599310.344827587
Capital expenditures: 2471724.1379310344
Depreciation & amortization: 14416551.724137932
Net tangible assets: 38063448.27586207
Owner earnings: 18544137.931034483
Return on net tangible assets (%): 48.71901724887665
Capex to operating income (%): 19.013262599469495
Buffett classification: The Great
Stock price: 0.6551724137931034
P/E ratio: 16.649830651060714
Shares outstanding: 167707610
Book value: 77562758.62068966
P/B ratio: 1.4166257313321358
Market cap (USD): 109877399.65517241
Debt to equity: 1.4528035139508828
Current ratio: 1.8842934135927767
Quick ratio: 0.9944425001749844
Effective tax rate (%): 34.296896457017304
Interest coverage ratio: 5.7000302388872095
COGS to revenue (%): 71.3023091579451
SG&A to revenue (%): 16.366647607405508
Free cash flow (dilution-adjusted): 4624137.931034483
Buyback yield (%): 0.367180400271765
Retained earnings: 12373103.448275862
Inventory turnover: 3.129022362407872
Receivables turnover: 5.668309186597037
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.17756183745583
FCF margin (%): 1.2018088971498937
Rule of 40 score: 1.2018088971498937
Financial ratios for NTD.AX — annual report dated 2023-06-30
Total revenue: 385618543.04635763
Gross profit: 108490728.47682118
Operating income: 15094039.735099338
Net income: 2205960.2649006625
Capital expenditures: 2266887.417218543
Depreciation & amortization: 15920529.801324503
Net tangible assets: 40398013.245033115
Owner earnings: 15859602.649006624
Return on net tangible assets (%): 39.258372813560435
Capex to operating income (%): 15.018427518427519
Buffett classification: The Great
Stock price: 0.37748344370860926
P/E ratio: 28.698089972981084
Shares outstanding: 167707610
Book value: 76384105.96026492
P/B ratio: 0.8287960612103344
Market cap (USD): 63306846.1589404
Debt to equity: 1.388486214669672
Current ratio: 2.125318496178046
Quick ratio: 1.0005026606347391
Effective tax rate (%): 24.902723735408564
Interest coverage ratio: 3.608041791989869
COGS to revenue (%): 71.86579057641976
SG&A to revenue (%): 16.719848046657642
Free cash flow (dilution-adjusted): 13286092.715231787
Buyback yield (%): 0
Retained earnings: 12775496.688741721
Inventory turnover: 3.2242040866644066
Receivables turnover: 7.540585340585341
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.743924100651803
FCF margin (%): 3.4453977784036653
Revenue growth (%): 0.22187980785729253
Rule of 40 score: 3.667277586260958
Financial ratios for NTD.AX — annual report dated 2024-06-30
Total revenue: 355620666.6666667
Gross profit: 112292666.66666667
Operating income: 16287333.333333334
Net income: 1042000
Capital expenditures: 2334000
Depreciation & amortization: 17180000
Net tangible assets: 44326000
Owner earnings: 15888000
Return on net tangible assets (%): 35.84352298876506
Capex to operating income (%): 14.330154312144405
Buffett classification: The Great
Stock price: 0.27999999999999997
P/E ratio: 45.06538464491362
Shares outstanding: 167707610
Book value: 78197333.33333334
P/B ratio: 0.6005080838221251
Market cap (USD): 46958130.8
Debt to equity: 1.513666280180057
Current ratio: 1.9437423415192976
Quick ratio: 0.8591854639317281
Effective tax rate (%): 63.56702845409211
Interest coverage ratio: 3.419314205738279
COGS to revenue (%): 68.42346995206502
SG&A to revenue (%): 18.544291576605033
Free cash flow (dilution-adjusted): 20382666.666666668
Buyback yield (%): 0
Retained earnings: 13902666.666666666
Inventory turnover: 2.4400960014975164
Receivables turnover: 7.127809401640878
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.878253348741543
FCF margin (%): 5.7315754052539125
Revenue growth (%): -7.779158165660284
Rule of 40 score: -2.047582760406372
Financial ratios for NURS.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.08661417322834646
Shares outstanding: 53665430
Market cap (USD): 4648186.8503937
Buyback yield (%): 0
Capitalized R&D asset: 150617
Rule of 40 score: 0
Financial ratios for NURS.V — annual report dated 2022-12-31
Total revenue: 4268431
Gross profit: 1835502
Operating income: -1959403
Net income: -5995220
Capital expenditures: 0
Operating cash flow: -329602
Depreciation & amortization: 37283
Net tangible assets: -612433
Owner earnings: -5957937
Buffett classification: The Gruesome
Stock price: 0.3676470588235294
Shares outstanding: 53665430
Book value: -356841
Market cap (USD): 19729937.5
Debt to equity: -0.05230060447089881
Current ratio: 0.8102607397990053
Quick ratio: 0.7779909749510171
Interest coverage ratio: -864.6968225948808
COGS to revenue (%): 56.99820378963605
SG&A to revenue (%): 72.81640490381595
Free cash flow (dilution-adjusted): -696121
Buyback yield (%): 0
Retained earnings: -6788116
Inventory turnover: 23.332748319283407
Receivables turnover: 224.0528581176841
Capitalized R&D asset: 100913.39
FCF margin (%): -16.30859207985323
Rule of 40 score: -16.30859207985323
Financial ratios for NURS.V — annual report dated 2023-12-31
Total revenue: 11509496
Gross profit: 4961450
Operating income: -1465134
Net income: -1937351
Capital expenditures: 2857
Operating cash flow: -402177
Depreciation & amortization: 108389
Net tangible assets: -2223876
Owner earnings: -1831819
Buffett classification: The Gruesome
Stock price: 0.3409090909090909
Shares outstanding: 53665430
Book value: -1830917
Market cap (USD): 18295032.954545453
Debt to equity: 0
Current ratio: 0.468408490170053
Quick ratio: 0.44486812102235984
Interest coverage ratio: -2421.7090909090907
COGS to revenue (%): 56.892552028342514
SG&A to revenue (%): 49.75098822746018
Free cash flow (dilution-adjusted): -1058382
Buyback yield (%): 0
Retained earnings: -8725467
Inventory turnover: 63.11187146395767
Receivables turnover: 207.21029795661175
Capitalized R&D asset: 49703.61
FCF margin (%): -9.195728466302954
Revenue growth (%): 169.64231119116133
Rule of 40 score: 160.44658272485836
Financial ratios for NURS.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.2
Shares outstanding: 53665430
Market cap (USD): 10733086
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NURS.V — quarterly report dated 2024-12-31
Total revenue: 4040578
Gross profit: 1371951
Operating income: 212010
Net income: 20577
Capital expenditures: 0
Operating cash flow: 470678
Depreciation & amortization: 62853
Net tangible assets: -3295017
Owner earnings: 83430
Return on net tangible assets (%): -2.5320051459522057
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.4335664335664335
P/E ratio: 934.6960087829748
Shares outstanding: 53665430
Book value: -1768743
Market cap (USD): 76932959.0909091
Debt to equity: 0
Current ratio: 0.391167471090478
Quick ratio: 0.391167471090478
COGS to revenue (%): 66.04567465347779
SG&A to revenue (%): 39.19367476633294
Free cash flow (dilution-adjusted): 37878
Buyback yield (%): 0
Retained earnings: -9130636
Receivables turnover: 24.790951370056323
Capitalized R&D asset: 0
FCF margin (%): 0.9374401385148362
Rule of 40 score: 0.9374401385148362
Financial ratios for NURS.V — annual report dated 2024-12-31
Total revenue: 16044716
Gross profit: 5696253
Operating income: 292171
Net income: -405169
Capital expenditures: 0
Operating cash flow: 856922
Depreciation & amortization: 181136
Net tangible assets: -3295017
Owner earnings: -224033
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.4335664335664335
Shares outstanding: 53665430
Book value: -1768743
Market cap (USD): 76932959.0909091
Debt to equity: 0
Current ratio: 0.391167471090478
Quick ratio: 0.391167471090478
COGS to revenue (%): 64.49763897347887
SG&A to revenue (%): 34.13869089362504
Free cash flow (dilution-adjusted): -940382
Buyback yield (%): 0.00965126012016011
Retained earnings: -9130636
Receivables turnover: 98.44229565729572
Capitalized R&D asset: 0
FCF margin (%): -5.861007449430704
Revenue growth (%): 39.40415809693144
Rule of 40 score: 33.54315064750074
Financial ratios for NURS.V — quarterly report dated 2025-03-31
Total revenue: 4540122
Gross profit: 1504465
Operating income: 78798
Net income: 20903
Capital expenditures: 1221
Operating cash flow: 354319
Depreciation & amortization: 101004
Net tangible assets: 1347326
Owner earnings: 120686
Return on net tangible assets (%): 8.957446082091492
Capex to operating income (%): 1.5495317140028935
Buffett classification: The Great
Stock price: 0.7762237762237764
P/E ratio: 498.21057655925864
Shares outstanding: 53665430
Book value: 3149062
P/B ratio: 13.228187545139706
Market cap (USD): 41656382.727272734
Debt to equity: 0
Current ratio: 1.4954124317104351
Quick ratio: 1.4954124317104351
COGS to revenue (%): 66.8628948737501
SG&A to revenue (%): 28.026912052143093
Free cash flow (dilution-adjusted): -22461
Buyback yield (%): 0
Retained earnings: -9109733
Receivables turnover: 32.75086924530752
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9874855853192719
FCF margin (%): -0.494722388517313
Revenue growth (%): 12.363181703211769
Rule of 40 score: 11.868459314694455
Financial ratios for NURS.V — quarterly report dated 2025-06-30
Total revenue: 5376519
Gross profit: 1930202
Operating income: 212833
Net income: 49867
Capital expenditures: 774
Operating cash flow: 214211
Depreciation & amortization: 107129
Net tangible assets: 1435021
Owner earnings: 156222
Return on net tangible assets (%): 10.886391209605991
Capex to operating income (%): 0.36366540902961475
Buffett classification: The Great
Stock price: 1.2846715328467153
P/E ratio: 754.7314112010039
Shares outstanding: 53665430
Book value: 3413485
P/B ratio: 20.197086033475497
Market cap (USD): 68942450.2189781
Debt to equity: 0
Current ratio: 1.48907444310451
Quick ratio: 1.48907444310451
COGS to revenue (%): 64.09941078976937
SG&A to revenue (%): 29.013382078627455
Free cash flow (dilution-adjusted): -192299
Buyback yield (%): 0
Retained earnings: -9059866
Receivables turnover: 18.920678770133833
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.104880881395642
FCF margin (%): -3.5766450374303522
Revenue growth (%): 18.422346359855528
Rule of 40 score: 14.845701322425175
Financial ratios for NURS.V — quarterly report dated 2025-09-30
Total revenue: 10519538
Gross profit: 2330320
Operating income: 688302
Net income: 361888
Capital expenditures: 0
Operating cash flow: -311642
Depreciation & amortization: 116657
Net tangible assets: 7169567
Owner earnings: 478545
Return on net tangible assets (%): 6.674670869244963
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.8057553956834536
P/E ratio: 332.21633321383536
Shares outstanding: 53665430
Book value: 9473056
P/B ratio: 15.89477247724205
Market cap (USD): 150572069.78417268
Debt to equity: 0.8329764967081372
Current ratio: 4.469282863085124
Quick ratio: 4.469282863085124
Interest coverage ratio: 5.131029855753103
COGS to revenue (%): 77.84769635320487
SG&A to revenue (%): 14.500266076323884
Free cash flow (dilution-adjusted): -698266
Buyback yield (%): 0
Retained earnings: -8697978
Receivables turnover: 23.02099992559426
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.866349510464166
FCF margin (%): -6.637801013694708
Revenue growth (%): 95.65704129381855
Rule of 40 score: 89.01924028012384
Financial ratios for NURS.V — quarterly report dated 2025-12-31
Total revenue: 14948859
Gross profit: 3238219
Operating income: 1232726
Net income: 1261646
Capital expenditures: 907
Operating cash flow: -2123151
Depreciation & amortization: 127982
Net tangible assets: 17164304
Owner earnings: 1388721
Return on net tangible assets (%): 8.090750431826423
Capex to operating income (%): 0.07357677212941076
Buffett classification: The Great
Stock price: 3.4525547445255476
P/E ratio: 109.35631088842597
Shares outstanding: 53665430
Book value: 19699444
P/B ratio: 9.405485503220481
Market cap (USD): 185282834.96350366
Debt to equity: 0.4242168459170726
Current ratio: 3.9823695310696805
Quick ratio: 3.9823695310696805
Interest coverage ratio: 2.726009433691059
COGS to revenue (%): 78.33801897522747
SG&A to revenue (%): 10.882014473479213
Free cash flow (dilution-adjusted): -2550671
Buyback yield (%): 0
Retained earnings: -7436332
Receivables turnover: 8.278141877692333
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.326560357736206
FCF margin (%): -17.06264672106413
Revenue growth (%): 42.105660914005924
Rule of 40 score: 25.043014192941794
Financial ratios for NURS.V — annual report dated 2025-12-31
Total revenue: 35385038
Gross profit: 9003206
Operating income: 2212659
Net income: 1694304
Capital expenditures: 2902
Operating cash flow: -1866263
Depreciation & amortization: 452772
Net tangible assets: 17164304
Owner earnings: 2144174
Return on net tangible assets (%): 12.49205327521582
Capex to operating income (%): 0.1311544164735732
Buffett classification: The Great
Stock price: 3.4525547445255476
P/E ratio: 109.35631088842597
Shares outstanding: 53665430
Book value: 19699444
P/B ratio: 9.405485503220481
Market cap (USD): 185282834.96350366
Debt to equity: 0.4242168459170726
Current ratio: 3.9823695310696805
Quick ratio: 3.9823695310696805
Effective tax rate (%): -52.096426554826124
Interest coverage ratio: 3.7735889923152226
COGS to revenue (%): 74.55646084087857
SG&A to revenue (%): 16.91459537220223
Free cash flow (dilution-adjusted): -3463697
Buyback yield (%): 0
Retained earnings: -7436332
Receivables turnover: 19.59496473353147
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.765880426459923
FCF margin (%): -9.788592003207683
Revenue growth (%): 120.54013296340054
Rule of 40 score: 110.75154096019286
Financial ratios for OLH.AX — annual report dated 2021-06-30
Total revenue: 17079699.2481203
Gross profit: 7169172.932330826
Operating income: -2435338.3458646615
Net income: -1944360.902255639
Capital expenditures: 851879.6992481203
Depreciation & amortization: 1806015.037593985
Net tangible assets: 2463909.77443609
Owner earnings: -990225.5639097743
Return on net tangible assets (%): -40.18919743667988
Buffett classification: The Gruesome
Stock price: 0.052631578947368425
Shares outstanding: 213059130
Book value: 3800751.879699248
P/B ratio: 2.950373709198814
Market cap (USD): 11213638.421052633
Debt to equity: 0.826112759643917
Current ratio: 0.9959488542853525
Quick ratio: 0.6708444106848969
Interest coverage ratio: -13.495833333333334
COGS to revenue (%): 58.025180489522796
SG&A to revenue (%): 45.659447085754536
Free cash flow (dilution-adjusted): 117293.23308270676
Buyback yield (%): 0
Retained earnings: -16364661.654135337
Inventory turnover: 5.132788161993769
Receivables turnover: 5.418893129770993
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -42.66332982086407
FCF margin (%): 0.6867406233491812
Rule of 40 score: 0.6867406233491812
Financial ratios for OLH.AX — annual report dated 2022-06-30
Total revenue: 16878620.689655174
Gross profit: 5982758.620689656
Operating income: -2584137.931034483
Net income: -2782068.9655172415
Capital expenditures: 166206.89655172414
Depreciation & amortization: 1518620.6896551724
Net tangible assets: -137931.03448275864
Owner earnings: -1429655.1724137932
Buffett classification: The Gruesome
Stock price: 0.034482758620689655
Shares outstanding: 213059130
Book value: 1114482.7586206887
P/B ratio: 6.5921760519802035
Market cap (USD): 7346866.551724138
Debt to equity: 4.989480198019806
Current ratio: 0.8452210103329506
Quick ratio: 0.5768513203214696
Interest coverage ratio: -5.729357798165138
COGS to revenue (%): 64.55422080575303
SG&A to revenue (%): 41.75860096428863
Free cash flow (dilution-adjusted): -1602068.9655172415
Buyback yield (%): 0
Retained earnings: -17973103.448275864
Inventory turnover: 4.224331550802138
Receivables turnover: 4.3240282685512375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -77.2577319587629
FCF margin (%): -9.491705483370106
Revenue growth (%): -1.1772956627866649
Rule of 40 score: -10.669001146156772
Financial ratios for OLH.AX — annual report dated 2023-06-30
Total revenue: 24927814.569536425
Gross profit: 10956953.642384106
Operating income: -815231.7880794702
Net income: -682781.4569536424
Capital expenditures: 1376158.940397351
Depreciation & amortization: 847682.119205298
Net tangible assets: 227152.3178807947
Owner earnings: -1211258.2781456956
Return on net tangible assets (%): -533.2361516034987
Buffett classification: The Gruesome
Stock price: 0.039735099337748346
Shares outstanding: 213059130
Book value: 1463576.158940399
P/B ratio: 5.784410769230763
Market cap (USD): 8465925.695364239
Debt to equity: 3.251131221719453
Current ratio: 0.9704629161551239
Quick ratio: 0.6878746298837295
Interest coverage ratio: -0.6923509561304836
COGS to revenue (%): 56.04526978560611
SG&A to revenue (%): 43.82455301400069
Free cash flow (dilution-adjusted): -472847.6821192053
Buyback yield (%): 0
Retained earnings: -18199337.74834437
Inventory turnover: 5.39125990288781
Receivables turnover: 5.7118361153262525
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.614927790525034
FCF margin (%): -1.8968677771578863
Revenue growth (%): 47.68869463850541
Rule of 40 score: 45.79182686134752
Financial ratios for PARR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.49
Shares outstanding: 50144277
Market cap (USD): 826879127.7299999
Buyback yield (%): 0
Capitalized R&D asset: 9591000
Rule of 40 score: 0
Financial ratios for PARR — annual report dated 2022-12-31
Total revenue: 7321785000
Gross profit: 846002000
Operating income: 441397000
Net income: 364189000
Capital expenditures: 53025000
Operating cash flow: 452606000
Depreciation & amortization: 99769000
Net tangible assets: 501635000
Owner earnings: 410933000
Return on net tangible assets (%): 81.91872576674275
Capex to operating income (%): 12.01299510418059
Buffett classification: The Great
Stock price: 23.25
P/E ratio: 3.2012346343519433
Shares outstanding: 50144277
Book value: 644537000
P/B ratio: 1.8088246916003272
Market cap (USD): 1165854440.25
Debt to equity: 1.350775828230187
Current ratio: 1.0489089176128288
Quick ratio: 0.46812255795417174
Effective tax rate (%): 0.19457438907752556
Interest coverage ratio: 6.463756443298969
COGS to revenue (%): 88.44541324280895
R&D to revenue (%): 0.12296181873682442
SG&A to revenue (%): 0.852196561357647
Free cash flow (dilution-adjusted): 390228000
Buyback yield (%): 0.6719535243456393
Retained earnings: -200687000
Inventory turnover: 6.214864349994194
Receivables turnover: 28.95302212468118
Capitalized R&D asset: 15428970
ROCI (R&D-adjusted, %): 29.57431087056026
FCF margin (%): 5.329683950020384
Rule of 40 score: 5.329683950020384
Financial ratios for PARR — annual report dated 2023-12-31
Total revenue: 8231955000
Gross profit: 1274016000
Operating income: 685585000
Net income: 728642000
Capital expenditures: 82277000
Operating cash flow: 579156000
Depreciation & amortization: 119830000
Net tangible assets: 1195231000
Owner earnings: 766195000
Return on net tangible assets (%): 64.10434468316166
Capex to operating income (%): 12.000991853672412
Buffett classification: The Great
Stock price: 36.37
P/E ratio: 2.5029402017588884
Shares outstanding: 50144277
Book value: 1335424000
P/B ratio: 1.3656691466455597
Market cap (USD): 1823747354.4899998
Debt to equity: 0.7627884477139845
Current ratio: 1.3049283058321488
Quick ratio: 0.5438144143943235
Effective tax rate (%): -18.80562068526967
Interest coverage ratio: 9.462870945479642
COGS to revenue (%): 84.5235305586583
R&D to revenue (%): 0.1384482786895701
SG&A to revenue (%): 1.1108782786106095
Free cash flow (dilution-adjusted): 485246000
Buyback yield (%): 3.7187716726786286
Retained earnings: 465856000
Inventory turnover: 5.996181472688179
Receivables turnover: 22.4151869712375
Capitalized R&D asset: 20594040
ROCI (R&D-adjusted, %): 29.11023649113158
Rosenberg metric: 47.54126402310341
FCF margin (%): 5.894662932438285
Revenue growth (%): 12.430985067165999
Rule of 40 score: 18.325647999604286
Financial ratios for PARR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.6
Shares outstanding: 50144277
Market cap (USD): 882539275.2
Buyback yield (%): 0
Capitalized R&D asset: 4006000
Rule of 40 score: 0
Financial ratios for PARR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.39
Shares outstanding: 50144277
Market cap (USD): 821864700.03
Buyback yield (%): 0
Capitalized R&D asset: 2684020
Rule of 40 score: 0
Financial ratios for PARR — annual report dated 2024-12-31
Total revenue: 7974457000
Gross profit: 741719000
Operating income: 36045000
Net income: -33322000
Capital expenditures: 135540000
Operating cash flow: 83776000
Depreciation & amortization: 131590000
Net tangible assets: 1052507000
Owner earnings: -37272000
Return on net tangible assets (%): -3.5412591080154336
Capex to operating income (%): 376.0299625468165
Buffett classification: The Gruesome
Stock price: 16.39
Shares outstanding: 50144277
Book value: 1191302000
P/B ratio: 0.689887786665346
Market cap (USD): 821864700.03
Debt to equity: 1.3153029206699896
Current ratio: 1.6166162075479786
Quick ratio: 0.6229549918040039
Interest coverage ratio: 0.43536289299820036
COGS to revenue (%): 90.69881497887567
SG&A to revenue (%): 1.3649079805684574
Free cash flow (dilution-adjusted): -77468000
Buyback yield (%): 17.274619532243886
Retained earnings: 295846000
Inventory turnover: 6.639693826779691
Receivables turnover: 20.02973142006023
Capitalized R&D asset: 10606980
ROCI (R&D-adjusted, %): 1.0658921516580437
Rosenberg metric: -46.70501009037466
FCF margin (%): -0.9714517239230207
Revenue growth (%): -3.1280297329127773
Rule of 40 score: -4.0994814568357985
Financial ratios for PARR — quarterly report dated 2025-03-31
Total revenue: 1745036000
Gross profit: 149090000
Operating income: -23290000
Net income: -30400000
Capital expenditures: 40933000
Operating cash flow: -1399000
Depreciation & amortization: 36586000
Net tangible assets: 973259000
Owner earnings: -34747000
Return on net tangible assets (%): -3.570169913661215
Buffett classification: The Gruesome
Stock price: 14.26
Shares outstanding: 50144277
Book value: 1111810000
P/B ratio: 0.643147111484876
Market cap (USD): 715057390.02
Debt to equity: 1.46760507640694
Current ratio: 1.5579211729471603
Quick ratio: 0.5414616177139272
Interest coverage ratio: -1.0660014646649578
COGS to revenue (%): 91.45633671740869
SG&A to revenue (%): 1.3892550067734992
Free cash flow (dilution-adjusted): -45878000
Buyback yield (%): 7.145999847448721
Retained earnings: 214260000
Inventory turnover: 1.5061891747012057
Receivables turnover: 4.540781622834066
Capitalized R&D asset: 1321980
ROCI (R&D-adjusted, %): -0.90796589689137
FCF margin (%): -2.629057509415279
Rule of 40 score: -2.629057509415279
Financial ratios for PARR — quarterly report dated 2025-06-30
Total revenue: 1893438000
Gross profit: 265247000
Operating income: 88229000
Net income: 59460000
Capital expenditures: 48126000
Operating cash flow: 133578000
Depreciation & amortization: 34712000
Net tangible assets: 1010110000
Owner earnings: 46046000
Return on net tangible assets (%): 4.55851342923048
Capex to operating income (%): 54.54669099729114
Buffett classification: The Good
Stock price: 26.53
P/E ratio: 45.778653434618036
Shares outstanding: 50144277
Book value: 1148415000
P/B ratio: 1.1584032504016406
Market cap (USD): 1330327668.81
Debt to equity: 1.3728756590605313
Current ratio: 1.42432209305503
Quick ratio: 0.5619214491603949
Effective tax rate (%): 22.118747298518606
Interest coverage ratio: 3.9911788654663893
COGS to revenue (%): 85.99124977950162
SG&A to revenue (%): 1.2489450407142986
Free cash flow (dilution-adjusted): 80976000
Buyback yield (%): 2.235313952885024
Retained earnings: 245553000
Inventory turnover: 1.5633450122374046
Receivables turnover: 4.898351037134002
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2824619748345447
FCF margin (%): 4.276664987182047
Revenue growth (%): 8.504237161869439
Rule of 40 score: 12.780902149051485
Financial ratios for PARR — quarterly report dated 2025-09-30
Total revenue: 2012936000
Gross profit: 522955000
Operating income: 354159000
Net income: 262631000
Capital expenditures: 32279000
Operating cash flow: 219358000
Depreciation & amortization: 36284000
Net tangible assets: 1258000000
Owner earnings: 266636000
Return on net tangible assets (%): 21.195230524642287
Capex to operating income (%): 9.11426788532834
Buffett classification: The Great
Stock price: 35.42
P/E ratio: 6.089013001223898
Shares outstanding: 50144277
Book value: 1396062000
P/B ratio: 1.2722288059842615
Market cap (USD): 1776110291.3400002
Debt to equity: 1.0123755248692394
Current ratio: 1.5147397991389047
Quick ratio: 0.48201619177022786
Effective tax rate (%): 23.9493596110466
Interest coverage ratio: 16.64906919894697
COGS to revenue (%): 74.02028678507413
SG&A to revenue (%): 1.2043105195594892
Free cash flow (dilution-adjusted): 183340000
Buyback yield (%): 0.9257307994986733
Retained earnings: 491747000
Inventory turnover: 1.102556854550177
Receivables turnover: 5.765825014679977
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.794687602961833
FCF margin (%): 9.108088881116934
Revenue growth (%): 6.311165192628436
Rule of 40 score: 15.419254073745371
Financial ratios for PARR — quarterly report dated 2025-12-31
Total revenue: 1813240000
Gross profit: 273211000
Operating income: 90496000
Net income: 77700000
Capital expenditures: 27535000
Operating cash flow: 93800000
Depreciation & amortization: 36743000
Net tangible assets: 1374780000
Owner earnings: 86908000
Return on net tangible assets (%): 6.321593273105515
Capex to operating income (%): 30.42675919377652
Buffett classification: The Good
Stock price: 35.14
P/E ratio: 4.7702025598349715
Shares outstanding: 50144277
Book value: 1552516000
P/B ratio: 1.134976962414558
Market cap (USD): 1762069893.78
Debt to equity: 0.7902527252537171
Current ratio: 1.6056714545046902
Quick ratio: 0.4947890675287668
Effective tax rate (%): 19.345107561964465
Interest coverage ratio: 5.274581803345574
COGS to revenue (%): 84.93244137565904
SG&A to revenue (%): 1.4513798504334783
Free cash flow (dilution-adjusted): 61427000
Buyback yield (%): 1.5645236376441916
Retained earnings: 541376000
Inventory turnover: 1.2532920677057944
Receivables turnover: 5.799176133456146
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3178457027232837
FCF margin (%): 3.387692748891487
Revenue growth (%): -9.920633343534021
Rule of 40 score: -6.532940594642534
Financial ratios for PARR — annual report dated 2025-12-31
Total revenue: 7464650000
Gross profit: 1210503000
Operating income: 509595000
Net income: 369391000
Capital expenditures: 148873000
Operating cash flow: 445337000
Depreciation & amortization: 144325000
Net tangible assets: 1374780000
Owner earnings: 364843000
Return on net tangible assets (%): 26.538282488834575
Capex to operating income (%): 29.213983653685773
Buffett classification: The Good
Stock price: 35.14
P/E ratio: 4.7702025598349715
Shares outstanding: 50144277
Book value: 1552516000
P/B ratio: 1.134976962414558
Market cap (USD): 1762069893.78
Debt to equity: 0.7902527252537171
Current ratio: 1.6056714545046902
Quick ratio: 0.4947890675287668
Effective tax rate (%): 23.182616229066003
Interest coverage ratio: 6.18568151196242
COGS to revenue (%): 83.7835263542162
SG&A to revenue (%): 1.3188830018822049
Free cash flow (dilution-adjusted): 279865000
Buyback yield (%): 7.08513325383376
Retained earnings: 541376000
Inventory turnover: 5.089691704095177
Receivables turnover: 23.873739893562583
Capitalized R&D asset: 3761010
ROCI (R&D-adjusted, %): 18.51841268152101
FCF margin (%): 3.7492045842738775
Revenue growth (%): -6.392999548433203
Rule of 40 score: -2.643794964159326
Financial ratios for PCQ.V — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 0.05511811023622048
Shares outstanding: 141889927
Market cap (USD): 7820704.637795276
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCQ.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -712900.7352941176
Net income: -720822.794117647
Capital expenditures: 0
Operating cash flow: -400544.85294117645
Net tangible assets: -744055.8823529411
Owner earnings: -720822.794117647
Buffett classification: The Gruesome
Stock price: 0.05147058823529412
Shares outstanding: 141889927
Book value: -744055.882352941
Market cap (USD): 7303158.007352942
Debt to equity: -0.039528972760584875
Current ratio: 0.40351258347402935
Quick ratio: 0.40351258347402935
Free cash flow (dilution-adjusted): -487965.44117647054
Buyback yield (%): 0
Retained earnings: -9163760.294117646
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCQ.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -1025933.3333333333
Net income: -881803.0303030303
Capital expenditures: 0
Operating cash flow: -368502.2727272727
Net tangible assets: -1280778.7878787878
Owner earnings: -881803.0303030303
Buffett classification: The Gruesome
Stock price: 0.030303030303030304
Shares outstanding: 141889927
Book value: -1280778.7878787878
Market cap (USD): 4299694.757575758
Debt to equity: -0.01774488533255098
Current ratio: 0.21108022607781032
Quick ratio: 0.21108022607781032
Free cash flow (dilution-adjusted): -607197.7272727273
Buyback yield (%): 0
Retained earnings: -9804124.242424242
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCQ.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.04444444444444444
Shares outstanding: 141889927
Market cap (USD): 6306218.977777777
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0